These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26609657)

  • 1. Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels.
    Bonnet U; Taazimi B; Montag M; Ronge R; Gespers H; Kuhlmann R; Grabbe D; Jahn J
    Psychiatr Danub; 2015 Dec; 27(4):424-5. PubMed ID: 26609657
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of clozapine intoxication presenting with atypical NMS symptoms.
    Kamış GZ; Ayhan Y; Basar K; Özer S; Anıl Yağcıoğlu AE
    Int J Neuropsychopharmacol; 2014 May; 17(5):819-21. PubMed ID: 24438505
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy.
    Mathur R; Singh J; Sood M
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):330-332. PubMed ID: 33675589
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and clozapine monotherapy.
    Chatterton R; Cardy S; Schramm TM
    Aust N Z J Psychiatry; 1996 Oct; 30(5):692-3. PubMed ID: 8902179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 9. Heat stroke during long-term clozapine treatment: should we be concerned about hot weather?
    Hoffmann MS; Oliveira LM; Lobato MI; Belmonte-de-Abreu P
    Trends Psychiatry Psychother; 2016; 38(1):56-9. PubMed ID: 27074342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P; Kruk J; Kneebone M; Kissane D
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
    Atbasoglu EC; Ozguven HD; Can Saka M; Goker C
    J Clin Psychiatry; 2004 Dec; 65(12):1724-5. PubMed ID: 15641884
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M; Ancill R
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.
    Brown TM
    Psychosomatics; 1999; 40(6):518-20. PubMed ID: 10581982
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical antipsychotics and neuroleptic malignant syndrome.
    Velamoor VR
    Can J Psychiatry; 2001 Nov; 46(9):865-6. PubMed ID: 11761644
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management.
    Garlipp P; Rosenthal O; Haltenhof H; Machleidt W
    J Psychopharmacol; 2002 Dec; 16(4):399-400. PubMed ID: 12503844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.